Parikh Asit 4
4 · Phathom Pharmaceuticals, Inc. · Filed Mar 21, 2025
Insider Transaction Report
Form 4
Parikh Asit
Director
Transactions
- Exercise/Conversion
Common Stock
2024-09-10$11.72/sh+7,500$87,900→ 93,000 total - Exercise/Conversion
Stock Option (Right to Buy)
2024-09-10−7,500→ 7,500 totalExercise: $11.72From: 2024-05-25Exp: 2033-05-24→ Common Stock (7,500 underlying)
Footnotes (1)
- [F1]The amount in column 5 shows the amount beneficially owned as of the filing date of this report.